Related Experiment Videos
4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists
A J Cocuzza1, F W Hobbs, C R Arnold
1DuPont Pharmaceuticals Company, Chemical and Physical Sciences Department, Experimental Station, Wilmington, DE 19880-0500, USA.
Bioorganic & Medicinal Chemistry Letters
|May 7, 1999
Abstract:
A series of 4-aryl-2-(N-ethylanilino)pyrimidines has been synthesized as corticotropin-releasing hormone (CRH) inhibitors. The effect of substitution on each aromatic ring on receptor binding was investigated.